This year HungaroTrial successfully completed a medical device study in patients with acute myocardial infarction in the CEE region for a US-based Sponsor.
HungaroTrial managed to set up 9 trial sites in Hungary, Serbia and Slovenia and enrolled 39 patients within 9 month. During this time the Sponsor’s sites enrolled a total of 11 patients at 5 sites in Austria, Poland and Estonia.
Share this
